SARS-COV-2 VACCINES AND NEURODEGENERATIVE DISEASE

Since December 2020, when several novel unprecedented vaccines against SARS-CoV-2 began to be approved for emergency use, there has been a worldwide effort to get these vaccines into the arms of as many people as possible as fast as possible. These vaccines have been developed “at warp speed,” given the urgency of the situation with the COVID-19 pandemic. Most governments have embraced the notion that these vaccines are the only path towards resolution of this pandemic, which is crippling the economies of many countries.

-

(Article)

14 views0 comments

Recent Posts

See All

The Dividing Line

We have been experiencing a lot of division in our country between friends, wives and husbands, brothers and sisters, extended families, social groups, companies, government institutions, and even chu